As co-transcriptional splicing often occurs in fast transcription (Naftelberg et al., 2015), our study also supports that the target genes of HNRNPK in regulatory model I are highly expressed in CML, because rapid transcription is more likely to produce highly expressed genes. The gene discussed is HNRNPK; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.